메뉴 건너뛰기




Volumn 66, Issue 4, 2011, Pages 901-911

Estimating prevalence of accumulated HIV-1 drug resistance in a cohort of patients on antiretroviral therapy

Author keywords

Antivirals; Drug susceptibility; HIV AIDS; Probability model; Resistant; Risk factors

Indexed keywords

NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

EID: 79952789456     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkr006     Document Type: Article
Times cited : (14)

References (32)
  • 1
    • 0442268112 scopus 로고    scopus 로고
    • A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less
    • Hammer SM, Squires KE, Hughes MD et al. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. N Engl J Med 1997; 337: 725-33.
    • (1997) N Engl J Med , vol.337 , pp. 725-733
    • Hammer, S.M.1    Squires, K.E.2    Hughes, M.D.3
  • 2
    • 0032507027 scopus 로고    scopus 로고
    • Improved survival among HIV-infected individuals following initiation of antiretroviral therapy
    • Hogg RS, Heath KV, Yip B et al. Improved survival among HIV-infected individuals following initiation of antiretroviral therapy. JAMA 1998; 279: 450-4.
    • (1998) JAMA , vol.279 , pp. 450-454
    • Hogg, R.S.1    Heath, K.V.2    Yip, B.3
  • 3
    • 2442723342 scopus 로고    scopus 로고
    • Treatment of human immunodeficiency virus infection with saquinavir, zidovudine and zalcitabine
    • Collier AC, Coombs RW, Schoenfeld DA et al. Treatment of human immunodeficiency virus infection with saquinavir, zidovudine and zalcitabine. N Engl J Med 1996; 334: 1011-7.
    • (1996) N Engl J Med , vol.334 , pp. 1011-1017
    • Collier, A.C.1    Coombs, R.W.2    Schoenfeld, D.A.3
  • 4
    • 48949097660 scopus 로고    scopus 로고
    • Antiretroviral treatment of adult HIV infection. 2008 recommendations of the International AIDS Society-USA panel
    • Hammer SM, Eron JJ, Reiss P et al. Antiretroviral treatment of adult HIV infection. 2008 recommendations of the International AIDS Society-USA panel. JAMA 2008; 300: 555-70.
    • (2008) JAMA , vol.300 , pp. 555-570
    • Hammer, S.M.1    Eron, J.J.2    Reiss, P.3
  • 5
    • 59649092052 scopus 로고    scopus 로고
    • Drug-resistant human immunodefiency virus
    • Kozal MJ. Drug-resistant human immunodefiency virus. Clin Microbiol Infect 2009; 15 Suppl 1: 69-73.
    • (2009) Clin Microbiol Infect , vol.15 , Issue.SUPPL. 1 , pp. 69-73
    • Kozal, M.J.1
  • 6
    • 58149522617 scopus 로고    scopus 로고
    • Broad advances in understanding HIV resistance to antiretrovirals: report on the XVII International HIV Drug Resistance Workshop
    • Mascolini M, Larder BA, Boucher CA et al. Broad advances in understanding HIV resistance to antiretrovirals: report on the XVII International HIV Drug Resistance Workshop. Antivir Ther 2008; 13: 1097-113.
    • (2008) Antivir Ther , vol.13 , pp. 1097-1113
    • Mascolini, M.1    Larder, B.A.2    Boucher, C.A.3
  • 7
    • 23244454080 scopus 로고    scopus 로고
    • The global status of resistance to antiretroviral drugs
    • Vella S, Palmisano L. The global status of resistance to antiretroviral drugs. Clin Infect Dis 2005; 41 Suppl 4: S239-46.
    • (2005) Clin Infect Dis , vol.41 , Issue.SUPPL. 4
    • Vella, S.1    Palmisano, L.2
  • 8
    • 0038234808 scopus 로고    scopus 로고
    • Antiretroviral drug resistance testing in adults infected with human immunodeficiency virus type 1: 2003 Recommendations of an International AIDS Society-USA panel
    • Hirsch MS, Brun-Vézinet FB, Clotet B et al. Antiretroviral drug resistance testing in adults infected with human immunodeficiency virus type 1: 2003 Recommendations of an International AIDS Society-USA panel. Clin Infect Dis 2003; 37: 113-28.
    • (2003) Clin Infect Dis , vol.37 , pp. 113-128
    • Hirsch, M.S.1    Brun-Vézinet, F.B.2    Clotet, B.3
  • 9
    • 19944403922 scopus 로고    scopus 로고
    • Updated European recommendations for the clinical use of HIV drug resistance testing
    • Vandamme A-M, Sönnerborg A, Ait-Khaled M et al. Updated European recommendations for the clinical use of HIV drug resistance testing. Antivir Ther 2004; 9: 829-48.
    • (2004) Antivir Ther , vol.9 , pp. 829-848
    • Vandamme, A.-M.1    Sönnerborg, A.2    Ait-Khaled, M.3
  • 10
    • 77950229001 scopus 로고    scopus 로고
    • Changes in the use of HIV antiretroviral resistance testing in a large cohort of U.S. patients, 1999 to 2006
    • Buchacz K, Baker RK, Young B et al. Changes in the use of HIV antiretroviral resistance testing in a large cohort of U.S. patients, 1999 to 2006. J Acquir Immune Defic Syndr 2010; 53: 625-32.
    • (2010) J Acquir Immune Defic Syndr , vol.53 , pp. 625-632
    • Buchacz, K.1    Baker, R.K.2    Young, B.3
  • 11
    • 79952805959 scopus 로고    scopus 로고
    • Predictors of having a resistance test following viral load (VL) failure of cART: data from EuroSIDA
    • Cologne, Germany
    • Fox Z, Phillips AN, Cozzi-Lepri A et al. Predictors of having a resistance test following viral load (VL) failure of cART: data from EuroSIDA. The 12th European AIDS Conference/EACS, Cologne, Germany, 2009. Abstract PE3.1/2.
    • (2009) The 12th European AIDS Conference/EACS
    • Fox, Z.1    Phillips, A.N.2    Cozzi-Lepri, A.3
  • 12
    • 17144369901 scopus 로고    scopus 로고
    • Long term probability of detection of HIV-1 drug resistance after starting antiretroviral therapy in routine clinical practice
    • Phillips AN, Dunn D, Sabin C et al. Long term probability of detection of HIV-1 drug resistance after starting antiretroviral therapy in routine clinical practice. AIDS 2005; 19: 487-94.
    • (2005) AIDS , vol.19 , pp. 487-494
    • Phillips, A.N.1    Dunn, D.2    Sabin, C.3
  • 13
    • 67649147982 scopus 로고    scopus 로고
    • Evolution and predictors of HIV type-1 drug resistance in patients failing combination antiretroviral therapy in Italy
    • Di Giambenedetto S, Zazzi M, Corsi P et al. Evolution and predictors of HIV type-1 drug resistance in patients failing combination antiretroviral therapy in Italy. Antivir Ther 2009; 14: 359-69.
    • (2009) Antivir Ther , vol.14 , pp. 359-369
    • Di Giambenedetto, S.1    Zazzi, M.2    Corsi, P.3
  • 14
    • 24644500647 scopus 로고    scopus 로고
    • Estimating HIV-1 drug resistance in antiretroviral-treated individuals in the United Kingdom
    • Pillay D, Green H, Matthias R et al. Estimating HIV-1 drug resistance in antiretroviral-treated individuals in the United Kingdom. J Infect Dis 2005; 192: 967-73.
    • (2005) J Infect Dis , vol.192 , pp. 967-973
    • Pillay, D.1    Green, H.2    Matthias, R.3
  • 15
    • 0035964694 scopus 로고    scopus 로고
    • Changes in the rate of genotypic resistance to antiretroviral drugs in Spain
    • Gallego O, Ruiz L, Vallejo A et al. Changes in the rate of genotypic resistance to antiretroviral drugs in Spain. AIDS 2001; 15: 1894-6.
    • (2001) AIDS , vol.15 , pp. 1894-1896
    • Gallego, O.1    Ruiz, L.2    Vallejo, A.3
  • 16
    • 60449087073 scopus 로고    scopus 로고
    • Nine-year trends in clinically relevant reduced susceptibility of HIV-1 to antiretrovirals
    • Sista P, Rinehart AR, Wasikowski B et al. Nine-year trends in clinically relevant reduced susceptibility of HIV-1 to antiretrovirals. J Clin Virol 2009; 44: 190-4.
    • (2009) J Clin Virol , vol.44 , pp. 190-194
    • Sista, P.1    Rinehart, A.R.2    Wasikowski, B.3
  • 17
    • 0742269873 scopus 로고    scopus 로고
    • Resistance of HIV-1 to multiple antiretroviral drugs in France: a 6-year survey (1997-2002) based on an analysis of over 7000 genotypes
    • Tamalet C, Fantini J, Tourres C et al. Resistance of HIV-1 to multiple antiretroviral drugs in France: a 6-year survey (1997-2002) based on an analysis of over 7000 genotypes. AIDS 2003; 17: 2383-8.
    • (2003) AIDS , vol.17 , pp. 2383-2388
    • Tamalet, C.1    Fantini, J.2    Tourres, C.3
  • 18
    • 3142660152 scopus 로고    scopus 로고
    • The prevalence ofantiretroviral drug resistance in the United States
    • Richman DD, Morton SC, Wrin T et al. The prevalence ofantiretroviral drug resistance in the United States. AIDS 2004; 18: 1393-401.
    • (2004) AIDS , vol.18 , pp. 1393-1401
    • Richman, D.D.1    Morton, S.C.2    Wrin, T.3
  • 19
    • 34547927815 scopus 로고    scopus 로고
    • Changing rates and patterns of drug resistance mutations in antiretroviral-experienced HIV-infected patients
    • De Mendoza C, Garrido C, Corral A et al. Changing rates and patterns of drug resistance mutations in antiretroviral-experienced HIV-infected patients. AIDS Res Hum Retroviruses 2007; 23: 879-85.
    • (2007) AIDS Res Hum Retroviruses , vol.23 , pp. 879-885
    • De Mendoza, C.1    Garrido, C.2    Corral, A.3
  • 20
    • 79952782160 scopus 로고
    • (9 October 2010, date last accessed)
    • Kirk O, Mocroft A, Lundgren JD et al. EuroSIDA amulticentre study, 1994-2009. http://www.cphiv.dk/EuroSIDA/Publications/EuroSIDAamulticentrestudy1994-2009/tabid/407/Default.aspx (9 October 2010, date last accessed).
    • (1994) EuroSIDA amulticentre study
    • Kirk, O.1    Mocroft, A.2    Lundgren, J.D.3
  • 21
    • 0027122957 scopus 로고
    • 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults
    • CDC
    • CDC. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morb Mortal Wkly Rep 1992; 41: 1-19.
    • (1992) MMWR Morb Mortal Wkly Rep , vol.41 , pp. 1-19
  • 22
    • 79952801290 scopus 로고    scopus 로고
    • Stanford University HIV Drug Resistance Database. (9 October, date last accessed)
    • Stanford University HIV Drug Resistance Database. HIVdb Program Genotypic Resistance Interpretation Algorithm. http://hivdb.stanford.edu/pages/algs/HIVdb.html (9 October 2010, date last accessed).
    • (2010) HIVdb Program Genotypic Resistance Interpretation Algorithm
  • 23
    • 40649106525 scopus 로고    scopus 로고
    • The incidence of multidrug and full class resistance in HIV-1 infected patients is decreasing over time (2001-2006) in Portugal
    • Vercauteren J, Deforche K, Theys K et al. The incidence of multidrug and full class resistance in HIV-1 infected patients is decreasing over time (2001-2006) in Portugal. Retrovirology 2008; 1: 5-12.
    • (2008) Retrovirology , vol.1 , pp. 5-12
    • Vercauteren, J.1    Deforche, K.2    Theys, K.3
  • 24
    • 72249107557 scopus 로고    scopus 로고
    • The incidence rate of HIV type-1 drug resistance in patients on antiretroviral therapy: a nationwide population-based Danish cohort study 1999-2005
    • Audelin AM, Lohse N, Obel N et al. The incidence rate of HIV type-1 drug resistance in patients on antiretroviral therapy: a nationwide population-based Danish cohort study 1999-2005. Antivir Ther 2009; 14: 995-1000.
    • (2009) Antivir Ther , vol.14 , pp. 995-1000
    • Audelin, A.M.1    Lohse, N.2    Obel, N.3
  • 25
    • 34848844088 scopus 로고    scopus 로고
    • Prevalence of HIV-1 drug resistance in treated patients. A French nationwide study
    • Costagliola D, Descamps D, Assoumou L et al. Prevalence of HIV-1 drug resistance in treated patients. A French nationwide study. J Acquir Immune Defic Syndr 2007; 46: 12-8.
    • (2007) J Acquir Immune Defic Syndr , vol.46 , pp. 12-18
    • Costagliola, D.1    Descamps, D.2    Assoumou, L.3
  • 26
    • 12144290307 scopus 로고    scopus 로고
    • Surveillance of HIV antiretroviral drug resistance in treated individuals in England: 1998-2000
    • Scott P, Arnold E, Evans B et al. Surveillance of HIV antiretroviral drug resistance in treated individuals in England: 1998-2000. J Antimicrob Chemother 2004; 53: 469-73.
    • (2004) J Antimicrob Chemother , vol.53 , pp. 469-473
    • Scott, P.1    Arnold, E.2    Evans, B.3
  • 27
    • 33747805631 scopus 로고    scopus 로고
    • Drug-class-wide resistance to antiretrovirals in HIV-infected patients failing therapy: prevalence, risk factors and virological outcome
    • Tozzi V, Zaccarelli M, Bonfigli S et al. Drug-class-wide resistance to antiretrovirals in HIV-infected patients failing therapy: prevalence, risk factors and virological outcome. Antivir Ther 2006; 11: 553-60.
    • (2006) Antivir Ther , vol.11 , pp. 553-560
    • Tozzi, V.1    Zaccarelli, M.2    Bonfigli, S.3
  • 29
    • 63649085185 scopus 로고    scopus 로고
    • Long-term trends of HIV type 1 drug resistance prevalence among antiretroviral treatment-experienced patients in Switzerland
    • Von Wyl V, Yerly S, Burgisser P et al. Long-term trends of HIV type 1 drug resistance prevalence among antiretroviral treatment-experienced patients in Switzerland. Clin Infect Dis 2009; 48: 979-87.
    • (2009) Clin Infect Dis , vol.48 , pp. 979-987
    • Von Wyl, V.1    Yerly, S.2    Burgisser, P.3
  • 30
    • 77955009720 scopus 로고    scopus 로고
    • Methods for estimating the prevalence of multidrug resistance in antiretroviral therapy-experienced patients in North America
    • San Francisco, CA Abstract 584. Foundation for Retrovirology and Human Health, Alexandria, VA, USA
    • Abraham AG, Gange SJ, Moore RD et al. Methods for estimating the prevalence of multidrug resistance in antiretroviral therapy-experienced patients in North America. In: Abstracts of the Seventeenth Conference on Retroviruses and Opportunistic Infections, San Francisco, CA, 2010. Abstract 584. Foundation for Retrovirology and Human Health, Alexandria, VA, USA.
    • (2010) Abstracts of the Seventeenth Conference on Retroviruses and Opportunistic Infections
    • Abraham, A.G.1    Gange, S.J.2    Moore, R.D.3
  • 32
    • 0000125534 scopus 로고
    • Sample selection bias as a specification error
    • Heckman J. Sample selection bias as a specification error. Econometrica 1979; 47: 153-61.
    • (1979) Econometrica , vol.47 , pp. 153-161
    • Heckman, J.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.